Pyroptosis Drives the Impairment of Colonic Barrier Integrity During Toxoplasma Gondii Chronic Infection
Immunology · 2026
DOI: 10.1111/imm.70023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2026. Verfasst von Xiaokang Tian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Pyroptosis, Colon, Toxoplasma, Toxoplasmosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Jiangsu Qing Lan Project, 333 High-level Talent Training Project of Jiangsu Province, Jiangsu Training Program of Innovation and Entrepreneurship for Undergraduates.
Abstract (Originalsprache)
Toxoplasma gondii ( T. gondii ) impairs gut barrier integrity in hosts, which helps the establishment of long‐term infection and is closely associated with disease progression. However, the precise mechanisms remain largely unclear. This study investigated whether pyroptosis, a form of inflammatory programmed cell death, contributes to the impairment of colonic barrier integrity induced by T. gondii chronic infection in mice. We found that the infection resulted in pronounced pathological damage in the colon, characterised by reduced colon length, decreased expression of tight junction proteins, and elevated serum LPS levels. Interestingly, the infection activated the pyroptosis pathway, supported by the higher expression of NLRP3 (NOD‐like receptor thermal protein domain associated protein 3), Caspase‐1, gasdermin D (GSDMD), GSDMD‐N, as well as IL‐1β and IL‐18. In addition, dimethyl fumarate, an anti‐pyroptogenic drug, significantly attenuated the infection‐induced pyroptosis and colonic pathology. Notably, macrophages exhibited pyroptosis post T. gondii infection, which was attenuated by DMF treatment. Overall, our results uncover that pyroptosis is vital for the impairments of gut barrier integrity post T. gondii chronic infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Xuzhou, China.
- The First Clinical Medical College, Xuzhou Medical University, Xuzhou, China.
- The Second Clinical Medical College, Xuzhou Medical University, Xuzhou, China.
- Department of Pathology, Basic Medical College, Xuzhou Medical University, Xuzhou, China.
ORCID-Profile: Wei Pan
Förderung
- Jiangsu Qing Lan Project
- 333 High-level Talent Training Project of Jiangsu Province
- Jiangsu Training Program of Innovation and Entrepreneurship for Undergraduates
- XZHMU-QL Joint Research Fund
- Jiangsu Province Postgraduate Scientific Research and Practice Innovation Program
Zitieren
APA
Tian, X., Xing, Y., Zhou, Y., Huang, Y., Zhang, Y., Guo, J., Wang, Q., Fu, L., Shi, Z., Yang, X., Pan, W., & Sun, F. (2026). Pyroptosis Drives the Impairment of Colonic Barrier Integrity During Toxoplasma Gondii Chronic Infection. Immunology. https://doi.org/10.1111/imm.70023
Vancouver
Tian X, Xing Y, Zhou Y, Huang Y, Zhang Y, Guo J, et al. Pyroptosis Drives the Impairment of Colonic Barrier Integrity During Toxoplasma Gondii Chronic Infection. Immunology. 2026. doi:10.1111/imm.70023
BibTeX
@article{Tian2026,
author = {Tian, Xiaokang and Xing, Yihui and Zhou, Yumeng and Huang, Yingting and Zhang, Yongsheng and Guo, Jiaxin and Wang, Qingling and Fu, Linlin and Shi, Zhen and Yang, Xiaoying and Pan, Wei and Sun, Fenfen},
title = {Pyroptosis Drives the Impairment of Colonic Barrier Integrity During Toxoplasma Gondii Chronic Infection},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70023}
}
EUVIMED